From 2021, it will be harder to import e-cigarettes. That protects young people, in particular, who are increasingly being lured into nicotine and tobacco addiction.
From 2021, Australians will no longer be able to buy nicotine-containing e-fluids, without both a prescription and someone licensed to import it for them, raising fears many will go back to smoking.
Bacterial changes could lead to serious diseases.
vchal/ Shutterstock
Weihong Lin, University of Maryland, Baltimore County and Rakaia Kenney, University of Maryland, Baltimore County
The FDA has banned flavored e-cigarettes that appeal to kids. But new research shows that the danger of flavors could go beyond their appeal to kids. The flavorings themselves could cause damage.
As new vaping-related lung diseases continue to be identified, jurisdictions around the world might want to take a look at new vaping regulations in British Columbia, Canada.
Vaping has been linked to more than 40 deaths and 2,000 illnesses in the U.S.
Oleksandr Zamuruiev/Shutterstock.com
Vaping continues to be in the news, with the CDC recently linking vitamin E acetate to the deaths and illnesses caused by vaping. But just what is vaping? And is it different from e-cigarettes?
A vitamin E acetate sample during a tour of the Medical Marijuana Laboratory of Organic and Analytical Chemistry at the Wadsworth Center in Albany, New York on Nov. 4, 2019.
Hans Pennink/AP Photo
A form of vitamin E could be behind recent vaping illnesses and death, as the vitamin was not meant to go into the lungs. Lax oversight of products and supplements only worsens the situation.
A new report in the Canadian Medical Association Journal describes a case of severe, life-threatening airway injury related to vaping that occurred in a Canadian youth.
(AP Photo/Tony Dejak)
Concerns about e-cigarettes are growing, with the AMA calling for a ban. With the Great American Smokeout on Nov. 21, it's worth asking: What do smokers think?
Senior Research Fellow, Departmental Lecturer and Co-Director of Evidence-Based Healthcare DPhil programme, Centre for Evidence-Based Medicine, University of Oxford